StockData
Cryoport, Inc. logo

Cryoport, Inc. (CYRX) stock

CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3021% above fair value
$19.74−0.06 (-0.30%)

Close on Nov 17, 2026Market cap $999.81MP/E –Yield –

Cryoport total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cryoport's total debt was $985.00K at Jun 30, 2026. For fiscal 2025 it was $1.09M, down 2.4% from the year before. The highest annual figure on record is $4.91M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.09M-2.4%
FY2024Dec 31, 2024$1.11M-16.6%
FY2023Dec 31, 2023$1.34M+276.1%
FY2022Dec 31, 2022$355.00K-67.3%
FY2021Dec 31, 2021$1.09M-77.9%
FY2020Dec 31, 2020$4.91M–
FY2019Dec 31, 2019$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$985.00K-25.8%
Q1 FY2026CQ1 2026Mar 31, 2026$1.03M-8.5%
Q4 FY2025CQ4 2025Dec 31, 2025$1.09M-2.4%
Q3 FY2025CQ3 2025Sep 30, 2025$1.29M+4.3%
Q2 FY2025CQ2 2025Jun 30, 2025$1.33M+5.6%
Q1 FY2025CQ1 2025Mar 31, 2025$1.12M-14.0%
Q4 FY2024CQ4 2024Dec 31, 2024$1.11M-16.6%
Q3 FY2024CQ3 2024Sep 30, 2024$1.24M+303.3%
Q2 FY2024CQ2 2024Jun 30, 2024$1.26M+262.5%
Q1 FY2024CQ1 2024Mar 31, 2024$1.31M+258.5%
Q4 FY2023CQ4 2023Dec 31, 2023$1.34M+276.1%
Q3 FY2023CQ3 2023Sep 30, 2023$307.00K-12.5%
Q2 FY2023CQ2 2023Jun 30, 2023$347.00K-7.2%
Q1 FY2023CQ1 2023Mar 31, 2023$364.00K-65.3%
Q4 FY2022CQ4 2022Dec 31, 2022$355.00K-67.3%
Q3 FY2022CQ3 2022Sep 30, 2022$351.00K-92.2%
Q2 FY2022CQ2 2022Jun 30, 2022$374.00K-91.8%
Q1 FY2022CQ1 2022Mar 31, 2022$1.05M-70.0%
Q4 FY2021CQ4 2021Dec 31, 2021$1.09M-77.9%
Q3 FY2021CQ3 2021Sep 30, 2021$4.51M–
Q2 FY2021CQ2 2021Jun 30, 2021$4.57M–
Q1 FY2021CQ1 2021Mar 31, 2021$3.50M–
Q4 FY2020CQ4 2020Dec 31, 2020$4.91M–
Q4 FY2019CQ4 2019Dec 31, 2019$0–

More Cryoport figures

See a number that looks wrong?